<DOC>
	<DOCNO>NCT02494050</DOCNO>
	<brief_summary>Anhedonia , characterize ( ) diminish motivation participate activity , and/or ( b ) diminish enjoyment pleasurable activity common symptom among woman diagnose mood disorder . This trial aim test three treatment adapt reduce anhedonia . The investigator compare three treatment group , specifically , two dos Behavioral Activation treatment anhedonia ( i.e. , 12 week vs. 8 week BA ) active comparator treatment , Bipolar Disorder Collaborative Care ( 12 week BDCC ) . BA psychotherapy approach help participant identify modify environmental source depression . BDCC supportive care approach educate participant optimize medication initiation exist medication regimen . The time frame study 12-14 week . Specifically , participant evaluate enrol within one week , receive 12 week treatment ( tracked time ) complete two evaluation ( one week 8 ) another end treatment ( expect average 12-14 week enrol treatment ) . Primary analysis aim compare dose-mechanism change BA relative standard medication optimize protocol , BDCC . The secondary analysis evaluate individual difference state patient preference treatment , group difference treatment effect anhedonia , side effect , quality life .</brief_summary>
	<brief_title>Telemedicine Women With Anhedonia Bipolar Unipolar Disorder</brief_title>
	<detailed_description>Prospective volunteer screen phone , eligible , invited clinical evaluation laboratory , locate Northwestern University . At laboratory , prospective volunteer complete write informed consent learn study . All evaluation measure follow variable : Anhedonia assess use Snaith-Hamilton Pleasure Scale , Temporal Experience Pleasure Scale , Effort-Expenditure Rewards Task ; Mood symptom assess Structured Clinical Interview DSM-IV , Inventory Depressive Symptomatology-Clinician Version , Clinician-Administered Rating Scale Mania , Inventory Depressive Symptomatology-Clinician version , Columbia Suicide Severity Rating Scale . Treatment preference measure Stated Preferences Inventory Bipolar Disorder . The presence side effect medication evaluate use Frequency , Intensity , Burden Side Effects measure . Maternal function evaluate use Barkin Index Maternal Function self-report . Behavioral Inhibition System/Behavioral Activation System Behavioral Activation Depression Scale use evaluate activation level . Reward processing measure use Monetary Incentive Delay Task computer Reward Probability Index questionnaire . Enrollment determine set criterion , whereby participant randomize one three treatment group use computerized randomized number generator use 1:1:1 ratio . Allocation concealment set person enrol participant know advance treatment participant receive . Moreover , evaluator remain blind treatment assignment . Participants randomize receive one three treatment : 12 week BA , 8 week BA option add 4 week , 12 week BDCC . Participants ask participate two follow-up evaluation laboratory , schedule Weeks 8 12 . The study end Week 12 evaluation ( approximately 12-14 week enrol treatment ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Anhedonia</mesh_term>
	<criteria>Currently experience score â‰¥ 20 clinicianadministered scale anhedonia Currently experience two symptom depression bipolar disorder either Type I II ( one symptom anhedonia ) OR Currently experience two symptom unipolar depression , without current psychotic feature ( one symptom anhedonia ) Currently medication mood disorder Proficiency English Able provide inform consent Current psychosis ( schizoaffective , schizophreniform , delusional disorder ) Current suicide risk sufficient preclude treatment outpatient basis Severe , unstable concurrent psychiatric condition likely require hospitalization within six month ( ex . hazardous substance use evidence score &gt; 10 Alcohol Use Disorders Identification Test &gt; 2 Drug Use Disorders identification Test ) Current incarcerated probation due criminal allegation Currently pregnant Cognitive impairment Those live United States VISA Those currently psychotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Anhedonia</keyword>
	<keyword>Women</keyword>
</DOC>